PhD in Pharmacy

Position as PhD Research Fellow in Pharmacovigilance available at the Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Norway./nA 4-year Phd Fellow position in pharmacovigilance is available at the Department of Pharmacy, University of Oslo. The candidate will be part of the UiO:Life Science convergence environment “UiO:Real-World Evidence: Capitalizing on Norwegian Health Data for Rapid Generation of Real-World Evidence on Effectiveness and Safety of Pharmaceutical”, funded by UiO:Life Science. The position is full-time for a duration of four years and includes 25% career promoting work within the UIO:Real-World Evidence convergence environment./nStarting date no later than 01.10.2026./nNo one can be appointed for more than one PhD Research Fellowship period at the University of Oslo./nThe place of work will be at the Department of Pharmacy’s premises on the Blindern campus. In 2026, the Department of Pharmacy will move into the new Life Sciences Building, which will offer modern teaching and research facilities./n/nThis PhD project integrates pharmacoepidemiology, causal inference, and machine learning to study real-world treatment patterns, effectiveness, and safety of monoclonal antibodies (mAbs) used in autoimmune, inflammatory, and neurological diseases. Using nationwide registry data, including the Norwegian Prescribed Drug Registry, the Norwegian Patient Registry, and the Norwegian Adverse Drug Reaction Register, the project will characterize mAb treatment patterns and assess real-world effectiveness and safety outcomes, including survival, relapse, infection, and adverse events. Machine learning methods will be applied for risk prediction, signal detection, and causal analyses, generating robust evidence to inform clinical practice and regulatory decision-making. A key objective is to assess the value of ADR registry reports versus diagnosis-based outcomes, and how their combination can improve safety signal detection.